THERESA SALES: Open Payments
NPI 1386153625 · JAMESTOWN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 16 payments from 7 companies in 2025. Trend: 2023 $123 · 2024 $225 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 5 | $92 |
| ABBVIE INC. | 4 | $86 |
| Novo Nordisk Inc | 3 | $85 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $19 |
Products named: Korlym, MAVYRET, Rybelsus, VOWST, Ozempic, APTIMA, Wegovy, QULIPTA.
Industry payments across CA — which companies pay providers there.
